[1]
M. L. N. Coelho, L. Saldanha, H. Auad, M. E. Castro, and R. Fraga, “GLP-1 RECEPTOR AGONISTS AND SGLT-2 INHIBITORS BEYOND GLYCEMIC CONTROL: CARDIOVASCULAR BENEFITS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS”, REASE, vol. 11, no. 10, pp. 2102–2110, Oct. 2025, doi: 10.51891/rease.v11i10.21484.